The use of a double‐blind drug trial in family therapy to demedicalize a problem | Zendy

Birleson Peter | Zendy; Sills John | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

The use of a double‐blind drug trial in family therapy to demedicalize a problem

Author(s) -

Birleson Peter,

Sills John

Publication year - 1981

Publication title -

journal of family therapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.52

H-Index - 45

eISSN - 1467-6427

pISSN - 0163-4445

DOI - 10.1046/j..1981.00544.x

Subject(s) - family therapy , double blind , drug , drug trial , pharmacotherapy , medicine , psychotherapist , clinical trial , psychology , psychiatry , alternative medicine , pathology , placebo

A family therapy approach to a problem that had led previous clinicians to diagnose and treat a child as ‘hyperkinetic’, is described. The resistance to change that the preceding diagnosis had inculcated, is described. A method of overcoming this resistance by active involvement of the family in a double‐blind trial of the drug treatment, was devised and used concurrently with a structural form of family therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research